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SUMMARY 
• Protein kinase C (PKC) is a family of phospholipid- 
dependent Ca
2+
/diacylglycerol-stimulated enzymes. It is an 
ubiquitous protein that plays a multifunctional role in the 
transduction of extracellular signals activating the phos- 
pholipid turnover and generating diacylglycerol (DAG). 
DAG can be produced from the hydrolysis of phospatidyl- 
inositol-1,4-bisphosphate, phosphatidylcholine, or sphin- 
gomyelin by respective phospholipases. PKC is also the 
major intracellular receptor for phorbol esters, potent tumor 
promoters, which may replace DAG for its activity. To date, 
12 different PKC isoforms have been described, all regu 
lated by phosphatidylserine and DAG, but only some being 
Co2*-dependent (a, fil, fill, and j). The 8, £, £, r\, 9, i, A, and 
H isoforms are Ca
2+
-independent. Each isoenzyme is a 
single polypeptide with four conserved (C1-C4) and five 
variable (V1-V5) regions. Cl and C2 regions constitute the 
regulatory domain and contain binding sites for phospha 
tidylserine, Ca~+, DAG, and phorbol esters, while C3 and 
C4 constitute the catalytic domain and contain binding 
sites for ATP, substrates, and various inhibitors. PKC isoen- 
zymes are involved in a variety of cellular responses in 
cluding growth, differentiation, neuronal development, 
synoptic transmission, secretion. They were first implicated 
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in the regulation of smooth muscle contraction with the 
observation that phorbol esters induce slowly developing, 
sustained contractions. Both Ca
2
*-dependent (a, ft) and 
Ca
2
*-independent (£, Q PKC isoforms have been identified in 
smooth muscle cells (SMC), and their involvement in the 
regulation of smooth muscle contractile state has been 
proved. Different isoenzymes may be activated by different 
contractile agonists in different SMC types. There are many 
potential targets for PKC in SMC that could play a role in the 
modulation of their contractily. Two actin filament-associated 
proteins, calponin and caldesmon, were shown to be substrates 
of PKC in SMC. They may regulate the interaction between 
actin and phosphorylated myosin. The phosphory-lated 
calponin or caldesmon alleviate the inhibition of the cross-
bridge cycling rate. (Biomed Rev 1997; 8: 87-100) 
INTRODUCTION 
• The contractile machinery of smooth muscle is under 
the control of various intracellular messengers and enzyme 
systems. Most of them, Ca2+-dependent or Ca2+-independent, 
modulate contractility in response to neuroendocrine factors. 
In this respect, the enzymes of the protein kinase C (PKC) 
family function as an important feedback system which couples 
contraction to the overall energy balance of smooth muscle 
cells (SMC). PKC was first implicated in the regulation of 
SMC contraction with the observation that phorbol esters 
induce slowly developing, sustained contractions (1-3). 
In this review we shall discuss the properties, isoenzymic 
forms, subcellular localization, regulation, and translocation of 
PKC with emphasis on the physiological role of this kinase 
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 Selected abbreviations 
CaM      - calmodulin 
DAG     - diacylglycerol 
IP,         - inositol trisphosphate 
MAPK   - mitogen-activated protein kinase 
MLCK   - myosin light-chain kinase 
PC         - phosphatidylcholine 
PIP2      - phosphatidylinositol bisphosphate 
PI-PLC  - phosphoinositide-specific phospholipase C 
PKC      - protein kinase C 
PLA,      - phospholipase A2 
PLC       - phospholipase C 
PLD      - phospholipase D                       :. 
PS         - phosphatidylserine 
SMC     - smooth muscle cell 
family in the regulation of smooth muscle contraction. 
Ca
2
 -CALMODULIN DEPENDENCE OF SMOOTH 
MUSCLE CONTRACTION 
• It is well known that the primary mechanism in the 
regulation of smooth muscle contraction involves the myosin 
phosphorylation/dephosphorylation cycle (Fig. 1). Various 
extracellular signals cause an increase of intracellular free 
calcium concentration ([Ca2+].). Calcium binds to calmodulin 
(CaM) to form Ca2T4-CaM which can interact with target 
proteins such as myosin light chain kinase (MLCK). The 
ternary complex Ca2+4-CaM-MLCK represents the active ki 
nase form (4) that catalyzes phosphorylation of the two 20-kD 
light chains of myosin. In turn, the phosphorylated myosin can 
bind to actin, forming acto-P-myosin which triggers cross- 
bridge cycling and development of force at the expense of 
adenosine trisphosphate (ATP) hydrolysis (5). Relaxation 
generally occurs upon removal of Ca2* from the cytosol, 
resulting in dissociation of the Ca2+4-CaM-MLCK complex 
and regeneration of inactive MLCK (6). Myosin is then de- 
phosphorylated by one or more myosin light chain phospha- 
tases (7). . 
PROTEIN KINASE C FAMILY IN SIGNAL 
TRANSDUCTION 
• PKC belongs to a family ofserine/threoninekinases, 
which has been shown to play a crucial role in signal transduc- 
tion in response to various stimuli such as growth factors, 
hormones, neurotransmitters, tumor promoters, thus being 
involved in the regulation of diverse cellularprocesses: growth, 
differentiation, metabolism, secretion, smooth muscle con 
traction (8-12).  
The discovery of the Ca2+/lipid-dependent PKC in 1977 (13, 
14) provided the first indication that the plasma membrane 
lipids could be recognized as precursors of second messenger 
molecules generated in the cell upon stimulation of cell 
surface receptors (14). The best characterized phospholipid 
pathway as a source of signal molecules is the 
phosphatidylinositol bisphosphate (PIP2) hydrolysis, which 
generates two second messengers: the water-soluble head-
group, inositol trisphosphate (IP3), and the lipid backbone, 
diacylglycerol (DAG) (16, 17). This hydrolysis requires the 
activation of phosphoinositide-specific phospholipase C (PI-
PLC), which is induced upon binding of an agonist to a specific 
cell surface receptor. Interaction between the receptor and PI-
PLC via a coupling G-protein causes activation of the enzyme 
(18, 19) (Fig. 2). IP3 induces Ca
2" release from the intracellular 
storage pools, which in turn causes translocation of the 
cytosolic PKC to the plasma membrane, where it is activated 
by DAG. Activation of PKC requires association of the 
enzyme with plasma membrane phospholipids, in particular 
phosphatidylserine (PS) (20, 21). In the absence of metal 
cations PKC binds PS by electrostatic interactions. The 
presence of Ca2" greatly enhances the binding in a 
concentration-dependent manner (22). It was postulated that 
Ca2T may participate in phospholipid clustering (23), and form a 
bridge between PKC and the acidic lipids (24). The estimated 
stoichiometry for PKC activation has suggested that for a 
complete activation of one PKC molecule are required one Ca2", 
one DAG, and four PS molecules (25). 
In addition to the classical inositol phospholipid turnover 
pathway, phosphatidylcholine (PC) also serves as a source of 
DAG (10, 15, 26, 27) (Fig. 3). An agonist-induced activation of 
phospholipase D (PLD) leads to hydrolysis of PC to phospha-
tidic acid (PA) and choline, PA being subsequently converted to 
DAG by a PA phosphohydrolase. Although PA is also proposed 
to be a direct activator of PKC (27, 28), the significance of this 
acidic lipid as a second messenger remains to be established. 
Alternatively, PC may be hydrolyzed by a PC-specific 
phospholipase C (PC-PLC) to form DAG directly (26-28). 
DAG molecules generated from PIP2 by PI-PLC activation 
undergo fast degradation. However, DAG concentration often 
increases again with a relatively slow onset, and persists for 
minutes, occasionally for hours (10). This second wave of DAG is 
thought to result from the PC hydrolysis, because the fatty 
acid composition of the secondary DAG matches that of PC. 
The sustained elevation of DAG is frequently observed in 
response to long-acting signals such as growth factors, cytokines, 
and phorbol esters (26, 29, 30). In addition, PKC can also be 
activated by lysoPC and cis-unsaturated fatty acids, including 
arachidonic, oleic, and linoleic acids derived from cell membrane 
phospholipids after their breakdown by phospholipase A, 
(PLA.) (15, 31, 32). 
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Figure 1. Schematic representation of myosin phosphorylation/dephosphorylation as a primary mechanism in regulation 
of smooth muscle contraction. CaM, calmodulin; MLCK, myosin light chain kinase; MLCP, myosin light chain 
phosphatase; ATP, adenosine trisphosphate; ADP, adenosine diphosphate; P., inorganic phosphate (according to Ref 5) 
 
Figure 2. Schematic illustration of signal transduction pathway by inositol phospholipid hydrolysis. PM, plasma 
membrane; R, receptor; Gp, G-protein; PLC, phospholipase C; PIPV phosphatidylinositol 4,5-bisphosphate; DAG, 
diacylglycerol; IP, inositol-l,4,5-trisphosphate; PS, phosphatidylserine. 
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transient PKC activation    sustained PKC activation 
Figure 3. PKC activation by signal-induced hydrolysis of plasma membrane phospholipids. PIPy phosphatidylinositol 4,5-
bisphosphate; PC, phosphatidylcholine; PI-PLC, phosphoinositide-specific phospholipase C; PC-PLC, phosphati-
dylcholine-specific phospholipase C; PLD, phospholipase D; PLAy phospholipase A2; SMase, sphingomyelinase IPy inositol 
1,4,5-trisphosphate; DAG, diacylglycerol; PA, phosphatidic acid; FFA, free fatty acids. 
  
Sphingomyelin (SM) hydrolysis is also recognized as a major 
phospholipid signalling pathway (33-36). Current results show 
that the action of a number of extracellular agents (i.e. 
dihydroxyvitamin D3, tumor necrosis factors, interleukins, 
and interferons) results in an early activation of 
sphingomyelinase (SMase) that cleaves membrane SM (Fig. 
3). SM breakdown products such as ceramide have emerged as 
potential mediators of the effects of these extracellular agents 
on cell growth, differentiation, and apoptosis (15, 35). 
Although the mechanisms underlying the action of ceramide 
are not clear, it appears that this molecule is also involved in 
the regulation of PKC activity. The action of ceramide on PKC 
is isoform-dependent, and comprises both direct and indirect 
effects. It has been shown that ceramide activates PKC^ in 
vitro and in vivo in NIH 3T3 cells (37), and inhibits PKCa 
translocation to the plasma membrane in both mouse epidermal 
cells and human skin fibroblasts (38). In addition, PKC is 
negatively regulated by sphingosine and lysosphingolipids. 
Sphingosine, the major breakdown product of the sphingo-
lipids, is a potent PKC inhibitor, competitive with respect to 
binding of DAG and phorbol esters, and noncompetitive in 
case of Ca2+ binding (33-36). Thus, PKC may be physiologically 
regulated by both positive (DAG) and negative (sphingosine 
and lysosphingolipids) messengers (35). 
Phorbol esters, potent tumor promoters, possess a molecular 
structure similar to that of DAG, and can substitute DAG in 
activating PKC (8, 10, 31, 39). Like DAG, they dramatically 
increase the affinity of PKC for Ca2+, resulting in its complete 
activation at a physiological Ca2+ concentration. Since phorbol 
esters are slowly metabolized, they persist in cells for a much 
longer times than DAG, and cause a prolonged activation of 
PKC. Furthermore, they induce an irreversible insertion of 
PKC into phospholipid vesicles (40), which possibly causes 
additional perturbation of the cell membrane. The effect of 
many biological agonists are mimicked by phorbol esters, 
implicating a role for PKC in the transduction of these signals. 
DOMAIN STRUCTURE AND ISOENZYMES OF 
PROTEIN KIMASE C 
• It has been established that PKC is not a single   
90 
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molecule entity, and that many closely related PKC isotypes 
exist. At present, the mammalian PKC family consists of 12 
different isoenzymes, indicated a, (31, pll, y, 5, e, £, r\, Q, i, X, 
and p. (8, 27, 41-43). The members of the PKC family are 
composed of a single polypeptide with a molecular weight of 
approximately 80 kDa, with a N-terminal regulatory region 
(20-40 kDa), and a C-terminal catalytic region (45 kDa). 
Comparison between the primary structures of PKC 
isoenzymes from cDNA sequence determinations revealed 
four conserved (C1-C4), and five variable (VI-V5) regions (Fig. 
4). The Cl and C2 regions constitute the regulatory domain 
and contain binding sites for PS, Ca2+, DAG, phorbol esters 
(their exact binding sites are not known). The C3 and C4 
regions constitute the catalytic domain and contain binding 
sites for ATP, PKC substrates, and various inhibitors (44-47).  
The Cl domain contains a pseudosubstrate (autoinhibitory) 
sequence resembling a PKC consensus phosphorylation site 
(48) with an alanine for serine/threonine substitution. This 
domain also contains two cysteine-rich, "zinc butterfly" motifs 
(designated CYS1 and CYS2), responsible for DAG and 
phorbol ester binding (49). The pseudosubstrate domain has 
been proposed to bind to the active site and maintain the kinase in 
an inactive state by steric inhibition. Binding of activators is 
thought to induce a conformational change that displaces the 
pseudosubstrate (47, 48). The C2 domain contains the Ca2+-
binding site (50), and deletion of this domain results in loss of 
the Ca2+ requirement for kinase activity (51). The regulatory 
and catalytic parts are separated by a hinge (V3) region that 
becomes proteolyrically labile when the enzyme is bound to the 
membrane. A proteolytically generated kinase domain (protein 
kinase M), free of pseudosubstrate inhibition, is constitutively 
active (13).  
Based on their structure and cofactor requirement, 
PKC isoenzymes can be divided into three groups: classical or 
conventional (cPKC), novel (nPKC), and atypical (aPKC) (8, 
10). All members of the PKC family require PS for their 
activation. The best characterized and first discovered are 
cPKC: a, two alternatively spliced variants |3I and (ill, and y. 
These isoenzymes are strictly Ca2+-dependent. The next well 
characterized arenPKC: 8, e, r\ (t), 6, andjj,. These isoenzymes 
are structurally similar to cPKC, but lack the C2 domain and 
exibit kinase activity that is Ca2+-independerrt. The least 
understood are aPKC: £ and A,. These differ significantly in 
structure - their C2 domain is absent (i.e. they are Ca2+-
mdependent), their Cl domain contains only one Cys-rich 
motif (not two), and furthermore, they have been reported not to 
respond to phorbol esters (10, 47). 
PKCa is present in most cell types, whereas the other 
isoforms appear to be expressed only in specific tissues. 
Multiple isoforms may coexit in the same cell type (8, 10, 
Ca    - DEPENDENT H7/STAUROSPORINE 
PROTEASE 
Figure 4. A putative structure of protein kinase C showing 
the regions involved in binding of substrates, cofac-tors 
and inhibitors. The pseudosubstrate sequence and the 
proteolitically labile hinge (V3) region between the 
regulatory and catalityc domains are also indicated. 
41). Differences in the subcellular localization of PKC 
isotypes have been also reported. Their compartmentation 
appears to be dynamic, and can change depending on the 
activation state of the cell. Recently, detailed studies using 
isolated subcellular structures or in situ immunocytochemical 
analysis have determined that in addition to the plasma 
membrane, PKC isoenzymes also translocate to the 
cytoskeleton, Golgi apparatus, endoplasmic reticulum, 
perinucleus, and nucleus (52, 53). It has been assumed that 
PKC may also bind to specific targeting proteins located at 
various subcellular sites, presumably in proximity to potential 
substrates. Using a PKC overlay assay with a cytoskeletal 
protein fraction and detection with anti-PKC(3, a class of PKC 
binding proteins termed receptors for activated C-kinase has 
been identified that binds to PKC only in the presence of PS, 
DAG, and Ca2+ (54). When PKC becomes activated, it causes 
phosphorylation of substrate proteins and undergoes 
autophosphorylation taking place at six basic amino acid residues 
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peptide, the C-terminal tail, and the hinge region between the 
regulatory and catalytic domain (55). Several lines of 
evidence suggest that PKC autophosphorylation increases the 
affinity of the enzyme for phorbol esters and Ca2+ (56), and 
accomplished at distinct sites may cause distinct types of 
enzyme regulation (55). 
PROTEIN KINASE C IN THE REGULATION OF SMOOTH MUSCLE 
CONTRACTION 
• The potential involvement of PKC in the regulation 
of the contractile state of vascular smooth muscle was origi 
nally suggested by the observation that phorbol esters, which 
specifically activate PKC (57), induce slow, sustained con 
tractions of a variety of vascular smooth muscle strips (1-3, 
58). In some instances, this results from an increase of [Ca2^ 
with activation of MLCK, phosphorylation of the 20-kDa light 
chains of myosin (LC20), and consequently, force develop 
ment (5). In other cases, however, phorbol ester-induced 
contractions occured without a change in [Ca2~].or an increase 
in myosin LC20 phosphorylation (3, 58-60). 
The mechanism of activation of SMC contractions by phorbol 
esters shows a considerable tissue specificity, and distinct 
PKC isoforms are engaged in different cell types upon action of 
different stimuli. Investigations using swine carotid artery have 
shown that phorbol 12,13-dibutyrate (PDB) increased the 
Ca2~- and phospholipid-dependent PKC activity in iso-
metrically contracting arterial smooth muscle strips with a 
time course which paralleled or preceded force development. 
The contractile agonist histamine had the same effect. Arterial 
SMC express both PKCa and PKC(3 as principal isoenzymes 
(61). In ferret portal vein, PKCa has also been implicated in the 
regulation of contraction (62), and this tissue displays a totally 
Ca2~-dependent contraction (52). On the other hand, PKC-
activating 12-deoxyphorbol 13-isobutyrate 20-acetate (DPBA) 
was shown to elicit a slow, sustained contractile response in 
ferret aortic strips (3), which was observed in the absence of 
extracellular Ca2\ No change in [Ca2+]j was detected with the 
photoprotein aequorin, and quantification of LC,0 
phosphorylation revealed no change in the resting level of 
myosin phosphorylation (3, 58). These studies suggest that 
proteins other than myosin, phosphorylated by PKC, may also be 
involved in regulation of SMC contraction. Furthermore, 
activation of PKC resulted in a contractile response to Ca2+ at 
resting [Ca2+], (220 nM), meaning that phorbol ester-induced 
contraction was Ca2"-independent (3). To test the hypothesis that 
PKC was indeed involved in the contractile response of the 
ferret aorta to phorbol esters, saponin-permeabilized single-
cell preparations were used. The advantage of this system is 
that it retains the contractile machinery functionally intact, and 
permits clamping of [Ca2+]i and addition of large 
molecules such as peptides and enzymes, which thereby have 
access to the contractile proteins.  Saponin-permeabilized 
single cells retained endogenous PKC since they responded to 
DPBA similarly to the intact cells. They also retained receptor 
coupling, i.e. the ability to contract in responce to oc-adrenergic 
stimulation. At pCa 7.0 (100 nM Ca2+, close to the resting 
[Ca2"].), phenylephrine elicited a significant force 
development, suggesting Ca2" sensitization of the contractile 
response. However, the phenylephrine-induced contraction still 
persisted at [Ca2+], close to zero (pCa 8.6), which suggests that 
phenylephrine triggers a Ca2+-independent pathway, and PKC-
mediated contraction is Ca2+-independent. The involvement of 
PKC in triggering contraction was confirmed by the addition of 
protein kinase M, the constitutively active catalytic . fragment 
of PKC generated by trypsin digestion. The advantage of protein 
kinase M over PKC is that phosphorylation of PKC substrates 
can be achieved in the absence of cofactors (Ca2*, 
phospholipids, DAG). Supplementation of protein kinase M to 
the medium bathing the permeabilized single cells resulted in a 
slow, sustained contraction similar to that induced in intact 
cells by phenylephrine (63). Other results also suggest the 
involvement of Ca2*-independent PKC in oxytocin-induced 
contractions of rat uterine SMC in the absense of extracellular 
Ca2+ (64). Such contractions occurred without a change in [Ca2T]., 
and in the absence of myosin LC20 phosphorylation. They were 
inhibited by the selective PKC inhibitors staurosporine and H-7 
(65). Prostaglandin F,a was also found to cause a Ca
2~-
independent contraction of permeabilized ferret aortic SMC, 
and this contraction was due, at least in part, to PKC 
activation, because it could be inhibited by the PKC 
pseudosubstrate peptide inhibitor and staurosporine, again 
implicating a Ca2+-independent PKC isoenzyme(s) 
involvement (66). 
The expression of Ca2Mndependent PKC isoenzymes in ferret 
aortic smooth muscle has been investigated by Western 
blotting using isoenzyme-specific antibodies (52, 67). Only 
PKCe and PKCt; have been detected, suggesting that these 
isoenzymes may be responsible for a Ca2~-independent 
contraction of the ferret aorta. Since PKCe but not PKCt; is 
responsive to phorbol esters, the former seems more likely to be 
involved in phorbol ester-induced contraction. Furthermore, 
upon stimulation of ferret aortic SMC with phenylephrine, 
PKCe translocated from the sarcoplasm to the sarco-lemma, 
whereas PKC^ translocated from a perinuclear localization to 
into the nucleus (52). Horowitz et al (68) purified PKCe and 
PKCt, free of other PKC isoenzymes, and examined their effects 
on permeabilized single ferret aortic SMC. They found that 
PKCe induced a slow, sustained contraction, similar to that 
caused by phenylephrine, that was reversed by the PKC 
pseudosubstrare peptide inhibitor. PKC^ on the other hand, 
failed to elicit a contractile response (68). These results support 
the hypothesis that the Ca2T-independent contraction 
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initiated by phenylephrine orphorbol ester is mediated by PKCe. 
POTENTIAL SUBSTRATES OF PROTEIN 
KINASE C IN VASCULAR SMOOTH MUSCLE 
• A great deal of efforts has been devoted to identify 
ing the substrate(s) of PKC involved in the contractile res 
ponses. The weight of evidence is against either myosin or 
MLCK being involved (67, and Refs therein). Probably of 
importance is PKC-catalyzed phosphorylation of proteins 
responsible for Ca
2+
 flux across the sarcolemma or sarcoplas- 
mic reticulum membrane, resulting in [Ca
2+
]. increase. In the 
cases of phorbol ester-induced contractions of vascular SMC 
that do not involve a [Ca
2+
]. increase or LC20 phosphorylation, 
it is necessary to look for other PKC substrates. Based largely 
on two-dimentional gel electrophoresis of proteins from 
32
P- 
labelled tissue treated with phorbol esters or various agonists, 
and in vitro phosphorylation of SMC proteins by purified PKC, 
the actin filament-associated proteins calponin (69-72), and 
caldesmon (5, 11, 73-75) have been implicated in the regula 
tion of smooth muscle contraction. 
Calponin is an actin- and CaM-binding protein found 
exclusively in smooth muscle. It inhibits SMC actomyosin 
ATPase through its interaction with actin. Calponin can be 
phosphory-lated by PKC or CaM kinase II, suspending its 
inhibition on the actomyosin ATPase activity (71). Calponin was 
found to be in vitro substrate of Ca
2+
-dependent PKC (a mixture 
of a, P and yisoenzym.es) (76), a very good substrate of PKCe, 
but a poor one of PKC  ̂ (77). The principal site of PKC 
phosphorylation was identified as serine 175, with 
substoichiometric phosphorylation at several other sites, 
including threonine 184 (72). Recent characterization of 
site-specific calponin mutants, in which serine 175 was 
replaced by alanine, aspartic acid or threonine suggested a 
key role for this residue in binding to actin, and the 
subsequent inhibition of actomyosin ATPase (78). 
Dephosphorylation of calponin by a protein phosphatase 
(identified as type 2A) restored actin binding and actomyosin 
ATPase inhibition (79). The participation of calponin in SMC 
contraction was confirmed in experiments with permeabilized 
ferret aortic cells (80). Addition of calponin to these cells, 
maximally contracted with phenylephrine or PKCe, resulted in 
about 50% reduction of steady-state force. When calponin was 
applied prior to PKCe, contraction was completely 
suppressed. Phosphorylated calponin, however, had no 
effect on contractile force; neither did a site-specific 
calponin mutant, in which the principal phosphorylation site 
(serine 175) was changed to alanine. 
The possible mechanisms of regulation of cross-bridge 
cycling in SMC by calponin are presented in Fig. 5. 




 via hydrolysis of PC by PC-PLC, or by 
the sequential action of PLD and phosphatidate phospho- 
hydrolase. This would result in specific activation of Ca
2+
- 
independent PKC isoenzymes; in the context of SMC con 
traction this is most likely to be PKCe. Phosphorylation of 
calponin results in its dissociation from the actin filament, and 
alleviation of its inhibition on cross-bridge cycling. A slow 
contraction would result due to the low level of myosin phos 
phorylation at resting [Ca
2+
]. (11). The origin of this basal 
myosin phosphorylation is still unclear. It may be due to MLCK 
autophosphorylation at threonine 803 in the absence of Ca
2+ 
(81), or to Ca
2+
-CaM dependent protein kinase II (which 
becomes constitutively active upon autophosphorylation and 
is able to phosphorylate LC20 at serine 19) (82). Another kinase 
may be also responsible (11). Activation of PI-PLC generates 
IP3 and DAG. IP3, via interaction with the IP3 receptor, trig 
gers the release of Ca
2+
 from the sarcoplasmic reticulum (83). 
DAG stimulates PKCe, and Ca
2+
 plus DAG stimulate PKCa 
andPKCp (expressed in vascular SMC) (61,77, 84). Ca
2+
will 
also activate MLCK via binding to CaM, resulting in an 
increase in myosin phosphorylation and a rapid rate of cross- 
bridge cycling. Therefore, the concomitant phosphorylation 
of calponin and myosin would result in maximal force develop 







 channels leads to activation of MLCK 
but not to production of DAG, and therefore, not to PKC 
activation (11).  
Caldesmon is another actin- and CaM-binding protein, found in 
both SMC and nonmuscle cells, which also inhibits 
actomyosin ATPase activity (73). Similar to calponin, the 
phosphorylation of caldesmon in vitro by PKC reversed its 
ability to inhibit the actomyosin ATPase (75). Adam and 
Hathaway (85) suggested that PKC may trigger indirectly 
caldesmon phosphorylation via the kinase cascade, involving 
Ras, Raf, mitogen-activated protein kinase kinase (MAPKK), 
and mi-togen-activated protein kinase (MAPK) (Fig. 6). 
Activation of PKC results in the conversion of Ras from the 
inactive GDP-bound form to the active GTP-bound form. 
Activated Ras converts Raf into an active state. This 
triggers sequential phosphorylation and activation of MAPKK 
and MAPK, which in turn phosphorylates 
caldesmon.Caldesmon phosphorylation has also been 
demonstrated in intact smooth muscle strips stimulated with 
a variety of contractile agonists (86-88), and the sites of MAPK 
phosphorylation were identified (85, 86). However, the 
individual steps of caldesmon phosphorylation by MAPK 
remain to be elucidated. 
INDIRECT EFFECTS OF PROTEIN KINASE C ON 
SMOOTH MUSCLE CONTRACTION 
• Despite proteins involved in the regulation of con 
traction, several other proteins were found to be targets of 
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Figure 5. Possible signalling pathways describing the regulation of smooth muscle contraction by phosphorylation of 
calponin. PI-PLC, phosphoinositide-specific phospholipase C; PLD, phospholipase D; PLC, phospholipase C; PC, 
phosphatidylcholine; PIPy phosphatidylinositol 4,5-bisphosphate; PA, phosphatidic acid; IPy inositol 1,4,5-trisphosphate; PA-
PHA, phosphatidate phosphohydrolase; DAG, diacylglycerol; CaP, calponin; P-CaP, phosphorylated calponin; PP2A, type 
2A protein phosphatase; PP1M, myosin light chain phosphatase. 
 
Protein kinase C and smooth muscle contraction 
  
PKC-induced phosphorylation, some of them related to intra-
cellular Ca2+ homeostasis, and cell membrane excitability. 
Recent studies have suggested that PKC may be stimulated 
also by processes independent of translocation. A pool of 
PKC resident in native membranes of various cells has been 
revealed, that can be directly stimulated by DAG or phorbol 
esters at very low concentrations (89). This finding raises the 
question about possible targets of the constantly membrane-
bound forms of PKC. The most prominent candidates are the 
membrane ion channels. 
Several studies have proved that PKC phosphorylate ion channels 
in SMC. Thus, the most widely expressed member of K+ 
channel family in mammalian SMC, Kvf,, was shown to be in 
vivo phosphorylated by PKC, leading to a decrease of the 
channel opening probability (90, 91). Phorbol esters were 
also found to suppress the ATP-sensitive K+ currents (92, 93) in 
guinea pig visceral SMC, and to slow down the inactivation of 
L-type Ca2+ current (94, 95). Inhibition of basal PKC activity 
by selective inhibitors was found to result in more than two-
fold increase of the Ca2+-sensitive K+ conductance in guinea pig 
ileum and rat tail artery (Duridanova et al, unpublished data), 
as well as to cause relaxation of guinea pig stomach antrum 
(96). In all the.se cases, the activation of PKC resulted in cell 
membrane depolarization, activation of Ca2+ entry, and 
increased cell excitability upon conventional stimuli. However, 
in certain SMC, phorbol esters were shown to suppress the 
voltage-sensitive Ca2+ entry (97, 98) or to attenuate the 
intracellular Ca2+ release (99). Controversial effects of phorbol 
esters have been observed in different types of SMC 
depending on their preexposure to various agonists (100, 
101). These data suggest that PKC-dependent modulation of 
ion channel activity may be an integrative consequence of 
various intracellular events comprising a cross-talk between 
two or more second messenger signalling pathways. 
CONCLUSION 
• The studies summarized above support the concept 
that other mechanisms, in addition to Ca2+/CaM-dependent 
activation of MLCK and phosphorylation of LC20, are involved 
in the regulation of smooth muscle contractile activity. Acti 
vation of PKC has been proposed to be an important pathway 
for regulating smooth muscle contraction. PKC is an integral 
part of the cell signalling machinery. Like most other signal 
ling proteins, this enzyme comprises a large family with multiple 
isoforms exhibiting individual characteristics and distinct 
patterns of tissue distribution. The biological significance of 
this heterogeneity has not been fully clarified, but the function 
of each PKC isoform in cell regulation is being investigated 
extensively. Both Ca2+-dependent (a, p) and Ca2+-indepen- 
dent (e, Q PKC isoenzymes have been identified in SMC, and 












upon different stimuli. The coupling between PKC activation 
and its biological effects is mediated by various protein 
substrates, which become phosphorylated in response to 
agonist stimulation. Calponin, a smooth muscle actin filament-
associated protein, has been implicated in the regulation of 
SMC contraction as a substrate of PKC. Recent evidence 
suggests that PKC may trigger a cascade of phosphorylation 
reactions, resulting in phosphorylation of another actin filament-
associated protein, caldesmon. However, evaluation of the 
importance of PKC-catalyzed phosphorylation of calponin 
and caldesmon in intact muscles requires further 
experimentation. Much work remains to be done to elucidate 
the mechanisms by which SMC contractions are mediated by 
members of PKC family via distinct substrate phosphorylation. 
Future studies on the regulation of smooth muscle contraction 
will   
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Figure 6. A putative signal transduction cascade of 
caldesmon phosphorylation by PKC (according to Ref 
75). MAPKK, mitogen-activated protein kinase 
kinase; MAPK, mitogen-activated protein kinase 
(subscribts i and a indicate inactive and active forms 
of the kinases, respectively); CaD and P-CaD, 
unphosphorylated and phosphorylated caldesmon. 
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focus on the molecular details of the signal transduction 
pathways, and the cross-talk between them. 
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